Many Oncologists Discuss, Recommend Medical Marijuana
THURSDAY, May 10, 2018 -- Many oncologists recommend medical marijuana (MM) clinically despite not feeling sufficiently knowledgeable about its utility, according to a study published online May 10 in the Journal of Clinical Oncology.
Ilana M. Braun, M.D., from the Dana-Farber Cancer Institute in Boston, and colleagues surveyed 400 medical oncologists regarding their beliefs, knowledge, and practices regarding MM (response rate, 63 percent).
The researchers found that only 30 percent of oncologists felt sufficiently informed to make recommendations regarding MM. Far more (80 percent) discussed MM with patients, while 46 percent clinically recommended MM. Roughly two-thirds of respondents viewed MM as a helpful adjunct to standard pain management strategies; a similar proportion viewed MM as equally or more effective than standard treatments for anorexia/cachexia.
"These findings are clinically important and suggest critical gaps in research, medical education, and policy regarding MM," the authors write.
© 2020 HealthDay. All rights reserved.
Posted: May 2018
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.